[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100556462":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":10,"centralContacts":10,"locations":10,"responsibleParty":20,"collaborators":10,"id":24,"slug":25,"hasResults":26,"nctId":27,"briefTitle":28,"officialTitle":28,"acronym":10,"eligibilityCriteria":29,"healthyVolunteers":26,"sex":30,"minAge":31,"maxAge":32,"enrollmentInfo":33,"targetDuration":10,"studyType":36,"phases":10,"briefSummary":37,"conditions":38,"keywords":10,"overallStatus":41,"whyStopped":10,"lastUpdateSubmitDate":42,"lastUpdatePostDateStruct":43,"startDateStruct":46,"completionDateStruct":48,"leadSponsor":50,"locationsCount":10},{"fullName":5,"class":6},"Fudan University","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"PAD group",null,"patients of peripheral artery disease who underwent endovascular treatment",[13],"Diagnostic Test: DCE MRI",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":10},"DIAGNOSTIC_TEST","DCE MRI","the recruited patients should complete pre- and post-operative DCE MRI workshops",[9],{"type":21,"investigatorFullName":22,"investigatorTitle":23,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Zhijun Bao","Director","100556462","foot-perfusion-by-dynamic-contrast-enhanced-mri-in-patients-with-peripheral-artery-disease-100556462",false,"NCT06525415","Foot Perfusion by Dynamic Contrast Enhanced MRI in Patients With Peripheral Artery Disease","Inclusion Criteria:\n\n* 18 to 80 years old;\n* PAD patients with Fontaine grade II-IV or Rutherford grade 2-6 and underwent a successful revascularization;\n* Patients completed both pre- and post-operative MRI workups;\n* Patients signed the informed consent form and be able to complete the clinical follow-up for 1 months.\n\nExclusion Criteria:\n\n* Patients has participated in other clinical studies;\n* Patients with Heart failure (NYHA III\u002FIV)\u002Fright to left shunt heart disease\u002F severe aortic and mitral insufficiency\u002Facute coronary syndrome\u002Fmalignant arrhythmia\u002Fsevere pulmonary hypertension (pulmonary artery pressure at least 90 mmHg)\u002Fmoderate to severe renal insufficiency (creatinine clearance rate\\\u003C60 ml\u002Fmin)\n* Any allergic constitution;\n* Pregnancy and childbirth;\n* Life expectancy\\\u003C12 months.","ALL","18 Years","80 Years",{"count":34,"type":35},30,"ESTIMATED","OBSERVATIONAL","We investigate the peri-operative foot perfusion through dynamic contrast enhanced MRI in patients with peripheral artery disease",[39,40],"Peripheral Arterial Disease","Perfusion","NOT_YET_RECRUITING","2024-07-24",{"date":44,"type":45},"2024-07-29","ACTUAL",{"date":47,"type":35},"2024-08-01",{"date":49,"type":35},"2024-11-30",{"name":5,"class":6}]